by Chris Lee | Apr 4, 2016 | Stock Analysis / Investing
1) Income Statement This is where you can find out how well the company is doing on how much money they earned or lost. Official definition from Investopedia: An income statement is a financial statement that measures a company’s financial performance over a... 
by Chris Lee | Apr 3, 2016 | Options
My Thought Process Nearing the end of March, one of my top stock holdings, Keryx Biopharmaceuticals (NASDAQ: KERX) announced that they had a positive result from their phase 3 study of ferric citrate for the treatment of iron deficiency anemia in adults with... 
by Chris Lee | Mar 16, 2016 | Stock Analysis / Investing
Stock Name Designer Shoe Warehouse Inc (NYSE: DSW) has two reportable segments: the DSW segment, which includes DSW stores and dsw.com, and the Affiliated Business Group (“ABG”) segment. DSW offers a wide assortment of brand name dress, casual and athletic footwear... ![[Edited] Here Is Why I Would Not Buy ComfortDelGro (SGX: C52.SI) Stock…](https://www.re-thinkwealth.com/wp-content/uploads/2016/03/Comfort-Delgro-Logo.jpg)
by Chris Lee | Mar 7, 2016 | Stock Analysis / Investing
How I Decided To Take A Look At This Company I already have my Indonesian Driving License from around 4 years back and I wanted to convert it to Singapore Driving License. Little did I know that It is not that simple- One of the criteria for conversion is that I have... 
by Chris Lee | Feb 28, 2016 | Stock Analysis / Investing
With the current market capitalization of $380.27 million, Keryx (NASDAQ: KERX) might not be your cheapest company to buy in terms of having a stake in their growth story. With growth story like this, there are risks involved. Current earning is still negative...